Takeda Pharmaceutical Company Limited: Takeda's QDENGA? (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union

The European Commission Approved QDENGA (TAK-003) for Use in Individuals Four Years of Age and Olderi QDENGA Becomes the Only Dengue Vaccine Approved in the EU for Use in Individuals Regardless of Previous